Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer

Mayo Clinic1 site in 1 country19 target enrollmentApril 2014

ConditionsPancreatic Cancer Non-Small-Cell Lung Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Pancreatic Cancer
Sponsor: Mayo Clinic
Enrollment: 19
Locations: 1
Primary Endpoint: Change in level of distress as measured by distress scores on the Distress Thermometer
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will evaluate feasibility and acceptability of providing the Dignity Therapy/Life Plan intervention to pancreatic or advanced lung cancer patients presenting for treatment in the outpatient medical oncology setting. Investigators hypothesize that providing dignity therapy to this population will be feasible.

Registry

clinicaltrials.gov

Start Date

April 2014

End Date

February 5, 2018

Last Updated

8 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Mayo Clinic

Responsible Party

Principal Investigator

Ann (Ann Marie) M. Dose, R.N., Ph.D.

Clinical Nurse Researcher

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

•Undergoing chemotherapy for pancreatic adenocarcinoma or advanced NSCLC (pancreatic arm closed)
•English-speaking
•Cognitively intact, per clinician judgment, as documented in electronic medical record (EMR)

Exclusion Criteria

•Currently receiving hospice or palliative care services
•Concurrent diagnosis of delirium or dementia, per medical record
•Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record
•Participating in other psychosocial intervention research studies.